STOCK TITAN

Honeywell Technologies Cdr Financials

HON
Trailing 12 months to June 30, 2026
Revenue $38.1B +5.0% YoY
Net Income $8.2B +43.7% YoY
EPS (Diluted) $7.36 FY2025 annual
Free Cash Flow $4.0B -25.7% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Honeywell Technologies Cdr (HON) reported $38.1B in revenue over the twelve months to Jun 30, 2026, up 5.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HON FY2025

Cash generation stays durable while rising leverage and financing costs turn operating resilience into weaker bottom-line returns.

In FY2025, operating cash flow of $6.4B exceeded net income of $4.7B, so accounting profit and cash production did not move in lockstep. Free-cash-flow margin held at 14.5% while gross margin was 36.9%, showing that reinvestment remained contained enough to preserve cash generation despite margin pressure.

Debt-to-equity rose from 1.4x in FY2024 to 2.0x in FY2025. Yet short-term liquidity stayed near 1.3x, even as equity fell to $13.9B; the balance sheet therefore became more sensitive to financing costs without showing a comparable squeeze in current obligations.

Operating profitability lost ground: EBITDA reached $9.5B, but net income was only $4.7B, making the gap between operating performance and reported earnings more consequential. Interest expense was $1.3B and net margin was 12.6%, so scale did not fully translate into shareholder earnings.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 64 / 100
Financial Health Score 64/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Honeywell Technologies Cdr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
93

Honeywell Technologies Cdr has an operating margin of 21.7%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 93/100, reflecting efficient cost management and pricing power. This is down from 22.1% the prior year.

Growth
56

Honeywell Technologies Cdr's revenue grew 7.8% year-over-year to $37.4B, a solid pace of expansion. This earns a growth score of 56/100.

Leverage
36

Honeywell Technologies Cdr has a moderate D/E ratio of 1.95. This balance of debt and equity financing earns a leverage score of 36/100.

Liquidity
33

Honeywell Technologies Cdr's current ratio of 1.30 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
78

Honeywell Technologies Cdr converts 14.5% of revenue into free cash flow ($5.4B). This strong cash generation earns a score of 78/100.

Returns
87

Honeywell Technologies Cdr earns a strong 34.0% return on equity (ROE), meaning it generates $34 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 87/100. This is up from 30.6% the prior year.

Altman Z-Score Grey Zone
2.65

Honeywell Technologies Cdr scores 2.65, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Honeywell Technologies Cdr passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.36x

For every $1 of reported earnings, Honeywell Technologies Cdr generates $1.36 in operating cash flow ($6.4B OCF vs $4.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
6.05x

Honeywell Technologies Cdr earns $6.05 in operating income for every $1 of interest expense ($8.1B vs $1.3B). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$37.4B
YoY+7.8%
5Y CAGR+2.8%
10Y CAGR-0.3%

Honeywell Technologies Cdr generated $37.4B in revenue in fiscal year 2025. This represents an increase of 7.8% from the prior year.

EBITDA
$9.5B
YoY+7.9%

Honeywell Technologies Cdr's EBITDA was $9.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.9% from the prior year.

Net Income
$4.7B
YoY-17.1%
5Y CAGR-0.2%
10Y CAGR-0.1%

Honeywell Technologies Cdr reported $4.7B in net income in fiscal year 2025. This represents a decrease of 17.1% from the prior year.

EPS (Diluted)
$7.36
YoY-15.5%
5Y CAGR+1.8%
10Y CAGR+2.0%

Honeywell Technologies Cdr earned $7.36 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 15.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$5.4B
YoY+3.8%
5Y CAGR+0.4%
10Y CAGR+2.0%

Honeywell Technologies Cdr generated $5.4B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 3.8% from the prior year.

Cash & Debt
$12.5B
YoY+26.1%
5Y CAGR-2.6%
10Y CAGR+8.6%

Honeywell Technologies Cdr held $12.5B in cash against $27.1B in long-term debt as of fiscal year 2025.

Dividends Per Share
$4.58
YoY+4.8%
5Y CAGR+4.8%
10Y CAGR+7.9%

Honeywell Technologies Cdr paid $4.58 per share in dividends in fiscal year 2025. This represents an increase of 4.8% from the prior year.

Shares Outstanding
636M
YoY-2.2%
5Y CAGR-1.8%
10Y CAGR-1.9%

Honeywell Technologies Cdr had 636M shares outstanding in fiscal year 2025. This represents a decrease of 2.2% from the prior year.

Margins & Returns

Gross Margin
36.9%
YoY-1.5pp
5Y CAGR+4.9pp
10Y CAGR+6.3pp

Honeywell Technologies Cdr's gross margin was 36.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.5 percentage points from the prior year.

Operating Margin
21.7%
YoY-0.4pp

Honeywell Technologies Cdr's operating margin was 21.7% in fiscal year 2025, reflecting core business profitability. This is down 0.4 percentage points from the prior year.

Net Margin
12.6%
YoY-3.8pp
5Y CAGR-2.0pp
10Y CAGR+0.3pp

Honeywell Technologies Cdr's net profit margin was 12.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.8 percentage points from the prior year.

Return on Equity
34.0%
YoY+3.4pp
5Y CAGR+6.8pp
10Y CAGR+7.9pp

Honeywell Technologies Cdr's ROE was 34.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.4 percentage points from the prior year.

Capital Allocation

R&D Spending
$1.8B
YoY+24.6%
5Y CAGR+6.3%
10Y CAGR-0.2%

Honeywell Technologies Cdr invested $1.8B in research and development in fiscal year 2025. This represents an increase of 24.6% from the prior year.

Share Buybacks
$3.8B
YoY+129.8%
5Y CAGR+0.5%
10Y CAGR+7.3%

Honeywell Technologies Cdr spent $3.8B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 129.8% from the prior year.

Capital Expenditures
$986.0M
YoY+13.2%
5Y CAGR+1.7%
10Y CAGR-0.8%

Honeywell Technologies Cdr invested $986.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 13.2% from the prior year.

HON Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HON quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$9.7B+6.3%$9.1B-6.3%$9.8B+3.4%$9.4B+1.2%$9.3B+4.4%$8.9B-2.7%$9.2B+4.0%$8.8B
Cost of Revenue$6.1B+8.2%$5.6BN/A$6.9B+21.3%$5.7B+3.6%$5.5BN/A$6.0B
Gross Profit$3.7B+3.2%$3.5B+2.0%$3.5B+7.3%$3.2B-11.8%$3.7B+5.8%$3.5B+2.9%$3.4B-1.6%$3.4B
R&D Expenses$524.0M+6.5%$492.0MN/A$497.0M+8.3%$459.0M+10.3%$416.0MN/A$368.0M
SG&A Expenses$1.3B+2.6%$1.3BN/A$1.3B-4.8%$1.4B+4.0%$1.3BN/A$1.4B
Operating Income$2.2B+5.2%$2.1BN/A$2.4B+13.1%$2.1B+6.3%$2.0BN/A$2.3B
Interest Expense$363.0M+2.0%$356.0MN/A$354.0M+7.6%$329.0M+15.4%$285.0MN/A$297.0M
Income Tax$1.6B+1634.1%$91.0MN/A$363.0M+48.8%$244.0M-33.9%$369.0MN/A$409.0M
Net Income$5.7B+592.1%$821.0M+813.9%-$115.0M-106.3%$1.8B+16.2%$1.6B+8.4%$1.4B+12.8%$1.3B-9.1%$1.4B
EPS (Diluted)$17.83$1.29+816.7%-$0.18-106.3%$2.86$4.90$2.22+13.3%$1.96-9.3%$2.16

HON Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HON quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$77.3B+4.5%$74.0B+0.4%$73.7B-8.9%$80.9B+3.2%$78.4B+4.3%$75.2B0.0%$75.2B+2.3%$73.5B
Current Assets$28.1B-8.2%$30.6B+0.7%$30.4B-1.2%$30.7B+9.9%$28.0B+1.2%$27.6B-0.9%$27.9B-0.9%$28.2B
Cash & Equivalents$8.8B-26.9%$12.0B-4.1%$12.5B-3.4%$12.9B+24.9%$10.3B+7.2%$9.7B-2.5%$9.9B-6.9%$10.6B
Inventory$6.4B+0.5%$6.4B+3.4%$6.2B-13.4%$7.1B+1.5%$7.0B+6.1%$6.6B+12.4%$5.9B-7.2%$6.3B
Accounts Receivable$8.3B+3.4%$8.1B+5.8%$7.6B-14.6%$8.9B+1.1%$8.8B+6.9%$8.3B+13.9%$7.2B-8.1%$7.9B
Goodwill$20.0B-5.3%$21.1B0.0%$21.1B-11.1%$23.7B-0.4%$23.8B+8.1%$22.0B+4.8%$21.0B-1.2%$21.3B
Total Liabilities$58.8B-2.6%$60.4B+1.0%$59.8B-6.8%$64.1B+2.9%$62.3B+7.9%$57.8B+2.1%$56.6B+0.9%$56.1B
Current Liabilities$23.2B+5.0%$22.1B-5.7%$23.4B+3.4%$22.6B+4.7%$21.6B-2.0%$22.1B+3.8%$21.3B+8.8%$19.5B
Long-Term Debt$26.2B-9.6%$29.0B+6.9%$27.1B-9.8%$30.1B-0.2%$30.2B+17.2%$25.7B+1.2%$25.4B-1.9%$25.9B
Total Equity$18.5B+36.4%$13.6B-2.3%$13.9B-17.1%$16.8B+4.3%$16.1B-7.8%$17.5B-6.2%$18.6B+7.0%$17.4B
Retained Earnings$56.0B+9.7%$51.0B+0.1%$51.0B-4.7%$53.5B+2.1%$52.4B+1.6%$51.5B+1.4%$50.8B+1.1%$50.3B

HON Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HON quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow$1.3B+296.3%-$650.0M-154.0%$1.2B-63.4%$3.3B+149.3%$1.3B+120.9%$597.0M-73.8%$2.3B+14.2%$2.0B
Capital Expenditures$315.0M+41.3%$223.0M+284.5%$58.0M-88.7%$512.0M+126.5%$226.0M+18.9%$190.0M+90.0%$100.0M-64.2%$279.0M
Free Cash Flow$961.0M+210.1%-$873.0M-176.2%$1.1B-58.7%$2.8B+154.0%$1.1B+168.6%$407.0M-81.3%$2.2B+26.9%$1.7B
Investing Cash Flow-$929.0M-680.7%-$119.0M+65.3%-$343.0M+29.7%-$488.0M+67.7%-$1.5B-306.7%-$371.0M+81.0%-$2.0B+30.1%-$2.8B
Financing Cash Flow-$3.5B-1415.7%$267.0M+120.3%-$1.3B-499.5%-$219.0M-128.9%$759.0M+164.3%-$1.2B-438.8%-$219.0M-112.4%$1.8B
Dividends Paid$795.0M+1.8%$781.0M+2.5%$762.0M+3.7%$735.0M-1.6%$747.0M+2.0%$732.0M-1.2%$741.0M+3.6%$715.0M
Share Buybacks$0-100.0%$1.0B+900.0%$100.0M0.0%$100.0M-94.1%$1.7B-10.5%$1.9B+318.0%$455.0M$0

HON Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

HON quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Gross Margin37.6%-1.1pp38.7%+3.1pp35.6%+1.3pp34.3%-5.0pp39.3%+0.5pp38.8%+2.1pp36.7%-2.1pp38.8%
Operating Margin23.1%-0.2pp23.3%N/A25.5%+2.7pp22.8%+0.4pp22.4%N/A26.0%
Net Margin58.5%+49.5pp9.0%+10.2pp-1.2%-20.5pp19.3%+2.5pp16.8%+0.6pp16.2%+2.2pp14.0%-2.0pp16.0%
Return on Equity30.6%+24.6pp6.0%+6.9pp-0.8%-11.7pp10.9%+1.1pp9.8%+1.4pp8.3%+1.4pp6.9%-1.2pp8.1%
Return on Assets7.3%+6.2pp1.1%+1.3pp-0.2%-2.4pp2.3%+0.3pp2.0%+0.1pp1.9%+0.2pp1.7%-0.2pp1.9%
Current Ratio1.21-0.2x1.39+0.1x1.30-0.1x1.36+0.1x1.290.0x1.25-0.1x1.31-0.1x1.44
Debt-to-Equity1.41-0.7x2.13+0.2x1.95+0.2x1.79-0.1x1.87+0.4x1.47+0.1x1.37-0.1x1.49
FCF Margin9.9%+19.4pp-9.6%-21.3pp11.7%-17.7pp29.4%+17.7pp11.7%+7.2pp4.6%-19.2pp23.8%+4.3pp19.5%

Similar Companies

Frequently Asked Questions

What is Honeywell Technologies Cdr's annual revenue?

Honeywell Technologies Cdr (HON) reported $37.4B in total revenue for fiscal year 2025. This represents a 7.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Honeywell Technologies Cdr's revenue growing?

Honeywell Technologies Cdr (HON) revenue grew by 7.8% year-over-year, from $34.7B to $37.4B in fiscal year 2025.

Is Honeywell Technologies Cdr profitable?

Yes, Honeywell Technologies Cdr (HON) reported a net income of $4.7B in fiscal year 2025, with a net profit margin of 12.6%.

Honeywell Technologies Cdr (HON) reported diluted earnings per share of $7.36 for fiscal year 2025. This represents a -15.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Honeywell Technologies Cdr (HON) had EBITDA of $9.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Honeywell Technologies Cdr (HON) had $12.5B in cash and equivalents against $27.1B in long-term debt.

Honeywell Technologies Cdr (HON) had a gross margin of 36.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Honeywell Technologies Cdr (HON) had an operating margin of 21.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Honeywell Technologies Cdr (HON) had a net profit margin of 12.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Honeywell Technologies Cdr (HON) paid $4.58 per share in dividends during fiscal year 2025.

Honeywell Technologies Cdr (HON) has a return on equity of 34.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Honeywell Technologies Cdr (HON) generated $5.4B in free cash flow during fiscal year 2025. This represents a 3.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Honeywell Technologies Cdr (HON) generated $6.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Honeywell Technologies Cdr (HON) had $73.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Honeywell Technologies Cdr (HON) invested $986.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Honeywell Technologies Cdr (HON) invested $1.8B in research and development during fiscal year 2025.

Yes, Honeywell Technologies Cdr (HON) spent $3.8B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Honeywell Technologies Cdr (HON) had 636M shares outstanding as of fiscal year 2025.

Honeywell Technologies Cdr (HON) had a current ratio of 1.30 as of fiscal year 2025, which is considered adequate.

Honeywell Technologies Cdr (HON) had a debt-to-equity ratio of 1.95 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Honeywell Technologies Cdr (HON) had a return on assets of 6.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Honeywell Technologies Cdr (HON) has an Altman Z-Score of 2.65, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Honeywell Technologies Cdr (HON) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Honeywell Technologies Cdr (HON) has an earnings quality ratio of 1.36x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Honeywell Technologies Cdr (HON) has an interest coverage ratio of 6.05x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Honeywell Technologies Cdr (HON) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top